IDHS Wellness Private limited (IWPL) is a Diagnostic and Healthcare company. Our focus is Rural Healthcare in India. We look at taking affordable and state of the art testing methodologies from across the world to the remotest corners of India. We are driven by good business practices and adhere to the highest ethical standards while dealing with clients, partners and regulators. We are also a gateway to businesses who are looking to venture into India with a long term view of making an alternative hub for various activities like Manufacturing, Research & Development & Knowledge processing.
India – An upcoming Healthcare story
On track to become world’s most populous country by 2025.
1.2 billion population, with 64% between 15 and 64 years. Large, diverse and treatment naive.
Increasing patient numbers in lifestyle disorders segment with large chronic disease patient pool.
Population in 65+ age bracket estimated to increase from 4% in 2010 to 6% in 2020, driving health spending.
India’s pharmaceutical sales saw double digit growth at 10.8% in 2016, the second highest among the BRIC nations.
Pharmaceutical sector expected to grow at 9.2% CAGR over 2016-2021 to reach US$ 25.6 billion.
By 2021, projected to be among top three pharmaceutical markets by YOY growth and ninth largest by absolute market size.
India’s disease burden is aligned with the new drug development focus of global pharmaceutical companies.
At IDHS Wellness we undertake our journey of bringing world class diagnostics and healthcare systems to India by collaborating with POC Medical Systems Inc. (www.pocmedicalsystems.com). POC Medical Systems Inc. is a silicon valley start-up which has created a unique platform called the Pandora CDx. This technology is a device which uses Microfluidics to detect various conditions through immunoassays in a CD loaded on the device. The first application developed by the company is MammoAlertTM which helps in early stage detection of Breast Cancer with a drop of blood.
Simplifying Breast Cancer Screening
MammoAlert™ circumvents the traditional problems associated with screening mammography by avoiding the cultural, geographic, and cost barriers keeping most women from being screened